On Friday, IO Biotech Inc (NASDAQ: IOBT) was 20.62% up from the session before settling in for the closing price of $0.86. A 52-week range for IOBT has been $0.32 – $2.79.
Annual sales at Healthcare sector company slipped by -27.25% over the past five years. When this article was written, the company’s average yearly earnings per share was at 14.48%. With a float of $49.27 million, this company’s outstanding shares have now reached $65.88 million.
Let’s look at the performance matrix of the company that is accounted for 80 employees.
IO Biotech Inc (IOBT) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward IO Biotech Inc stocks. The insider ownership of IO Biotech Inc is 25.21%, while institutional ownership is 41.38%. The most recent insider transaction that took place on May 30 ’25, was worth 20,884. In this transaction Director of this company bought 15,000 shares at a rate of $1.39, taking the stock ownership to the 15,000 shares. Before that another transaction happened on Dec 23 ’24, when Company’s Chief Medical Officer bought 31,350 for $0.85, making the entire transaction worth $26,553. This insider now owns 31,350 shares in total.
IO Biotech Inc (IOBT) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.34 earnings per share (EPS) during the time that was better than consensus figure (set at -0.35) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.48% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.32% during the next five years compared to -27.25% drop over the previous five years of trading.
IO Biotech Inc (NASDAQ: IOBT) Trading Performance Indicators
You can see what IO Biotech Inc (IOBT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.96.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.58, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of IO Biotech Inc (IOBT)
IO Biotech Inc (NASDAQ: IOBT) saw its 5-day average volume 1.58 million, a negative change from its year-to-date volume of 2.04 million. As of the previous 9 days, the stock’s Stochastic %D was 44.73%.
During the past 100 days, IO Biotech Inc’s (IOBT) raw stochastic average was set at 29.05%, which indicates a significant decrease from 72.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1542 in the past 14 days, which was lower than the 0.1727 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2057, while its 200-day Moving Average is $1.2343. Nevertheless, the first resistance level for the watch stands at $1.1138 in the near term. At $1.1875, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.3051. If the price goes on to break the first support level at $0.9225, it is likely to go to the next support level at $0.8049. The third support level lies at $0.7312 if the price breaches the second support level.
IO Biotech Inc (NASDAQ: IOBT) Key Stats
There are 65,880K outstanding shares of the company, which has a market capitalization of 68.52 million. As of now, sales total 0 K while income totals -95,490 K. Its latest quarter income was 0 K while its last quarter net income were -26,220 K.
